Vaxart Earnings Calls

Jun 30, 2026 (Upcoming)
Release date Aug 12, 2026
EPS estimate -$0.210
EPS actual -
Revenue estimate 50.5M
Revenue actual -
Expected change +/- 11.21%
Mar 31, 2026
$0.0200 (109.52%)
Release date May 07, 2026
EPS estimate -$0.210
EPS actual $0.0200
EPS Surprise 109.52%
Revenue estimate 50.5M
Revenue actual 39.227M
Revenue Surprise -22.32%
Dec 31, 2025
$0.240 (400.00%)
Release date Mar 12, 2026
EPS estimate -$0.0800
EPS actual $0.240
EPS Surprise 400.00%
Revenue estimate 35.95M
Revenue actual 104.239M
Revenue Surprise 189.96%
Sep 30, 2025
-$0.0400 (42.86%)
Release date Nov 13, 2025
EPS estimate -$0.0700
EPS actual -$0.0400
EPS Surprise 42.86%
Revenue estimate 35.95M
Revenue actual 72.413M
Revenue Surprise 101.43%

Last 4 Quarters for Vaxart

Below you can see how VXRT performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sep 30, 2025 Beat
Release date Nov 13, 2025
Price on release $0.365
EPS estimate -$0.0700
EPS actual -$0.0400
EPS surprise 42.86%
Date Price
Nov 07, 2025 $0.410
Nov 10, 2025 $0.399
Nov 11, 2025 $0.375
Nov 12, 2025 $0.367
Nov 13, 2025 $0.365
Nov 14, 2025 $0.381
Nov 17, 2025 $0.370
Nov 18, 2025 $0.391
Nov 19, 2025 $0.389
4 days before -10.98%
4 days after 6.58%
On release day 4.38%
Change in period -5.12%
Dec 31, 2025 Beat
Release date Mar 12, 2026
Price on release $0.725
EPS estimate -$0.0800
EPS actual $0.240
EPS surprise 400.00%
Date Price
Mar 06, 2026 $0.730
Mar 09, 2026 $0.800
Mar 10, 2026 $0.770
Mar 11, 2026 $0.751
Mar 12, 2026 $0.725
Mar 13, 2026 $0.631
Mar 16, 2026 $0.680
Mar 17, 2026 $0.675
Mar 18, 2026 $0.635
4 days before -0.658%
4 days after -12.41%
On release day -12.97%
Change in period -12.99%
Mar 31, 2026 Beat
Release date May 07, 2026
Price on release $0.740
EPS estimate -$0.210
EPS actual $0.0200
EPS surprise 109.52%
Date Price
May 01, 2026 $0.770
May 04, 2026 $0.760
May 05, 2026 $0.760
May 06, 2026 $0.745
May 07, 2026 $0.740
May 08, 2026 $0.700
May 11, 2026 $0.652
May 12, 2026 $0.690
May 13, 2026 $0.690
4 days before -3.90%
4 days after -6.80%
On release day -5.41%
Change in period -10.43%
Jun 30, 2026 (Upcoming)
Release date Aug 12, 2026
Price on release -
EPS estimate -$0.210
EPS actual -
Date Price
Jul 07, 2026 $0.550
Jul 08, 2026 $0.550
Jul 09, 2026 $0.541
Jul 10, 2026 $0.546
Jul 13, 2026 $0.534

Vaxart Earnings History

Earnings Calendar

FAQ

When is the earnings report for VXRT?
Vaxart (VXRT) has scheduled its earnings report for Aug 12, 2026 after the markets close.

What is the VXRT price-to-earnings (P/E) ratio?
VXRT P/E ratio as of Jul 13, 2026 (TTM) is 3.82.

What is the VXRT EPS forecast?
The forecasted EPS (Earnings Per Share) for Vaxart (VXRT) for the first fiscal quarter 2026 is -$0.210.

What are Vaxart's retained earnings?
On its balance sheet, Vaxart reported retained earnings of $39.23 million for the latest quarter ending Mar 31, 2026.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
ABOUT VAXART
Vaxart
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1 and GII.4 norovirus strains; seasonal influenza vaccine, which is in Phase II clinical trial for the t...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
10.58% Jun 29
NMRK
$15.02
0.466% Jun 24
X
XMAX
$8.34
2.40% Jun 24
NESR
$25.07
12.49% Jun 23
CAG
$13.43
6.70% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE